Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples